VIC Technology Venture Development

VIC Technology Venture Development is a venture capital firm that focuses on forming and nurturing life science and emerging technology companies by exclusively licensing innovative technologies from leading research institutions worldwide. Their unique business model emphasizes risk management and capital efficiency, enabling technical teams to concentrate on product development while experienced business professionals handle financing and growth strategies. By providing substantial seed investments ranging from $250,000 to $500,000 through the VIC Investor Network, VIC aims to successfully transition innovations from research labs to the market.

The firm's investment strategy involves assembling world-class teams and offering unique investment opportunities to accredited investors, fostering a sustainable and healthy future through transformative technologies. VIC's portfolio includes companies based on innovations licensed from institutions such as Colorado State University, Georgia Tech, Johns Hopkins, Massachusetts General Hospital, Stanford, University of Colorado, University of New Mexico, University of Texas Southwestern, Virginia Tech, and Washington University. Technologies include therapeutics, vaccines, medical devices, diagnostics, and related opportunities.

VIC's expansion efforts include establishing a new office in Minnesota to tap into regional innovation across the upper Midwest. This move further supports their model of accessing top-tier science in locations where early-stage, life science-focused capital is limited. The firm continues to build deeper relationships with life science ecosystems in Minnesota and surrounding states, aiming to advance technologies from proof of concept to commercial product roll-out.